The Three Perils of Wearable Data

Sponsors considering using data from sensors and wearables in their clinical trials worry about three scenarios: collecting too little data, collecting too much data, and collecting bad data. Each outcome could likely impact their study or a portion of it with a significant waste of time, money, and patient goodwill.

Incorporating Caregivers Into ePRO Technology to Support Cancer Patients

Caregivers play a critical role in oncology trials, providing support and assistance to patients who are dealing with physical, emotional, or cognitive challenges related to their illness and treatment. Caregivers are made up of a wide range of individuals including parents of minor children, adult children of parents, spouses or partners of participants, and home health aides.

Debunking Complex Data Preparation and Analysis

We all benefit from many technological advances—from GPS to AI/ML to ChatGPT—without questioning exactly how they work. There’s no real need to understand what goes on “behind the curtain” or “under the hood.” The focus is on what is created over how output and results are created.

Paper vs. Electronic Clinical Outcome Assessments (COA)

Business purchases are driven by a sticker price. Then there’s the true, all-inclusive cost that accumulates the soft costs, the downstream costs, and even the cost of unintended consequences. Savvy decision makers attempt to consider them all, but it usually isn’t an easy exercise.

eSource: Power to the Patient

As Sponsors incorporate eSource technologies and decentralized data collection into their trials, barriers to patient participation and adherence are beginning to fall away.

Scroll to Top